司太立: 司太立第五届董事会第十七次会议决议公告

Meeting Overview - The fifth board meeting of Zhejiang Sitaili Pharmaceutical Co., Ltd. was held on August 28, 2025, combining in-person and communication methods for voting [1] - All 7 directors attended the meeting, with some participating via communication [1] - The meeting was convened and presided over by Chairman Hu Jian [1] - The meeting complied with the relevant laws, regulations, and the company's articles of association [1] Resolutions Passed - The board approved the "2025 Half-Year Report (Full Text and Summary)" with a unanimous vote of 7 in favor [2] - The board approved the "2025 Half-Year Special Report on the Storage and Use of Raised Funds," also with a unanimous vote of 7 in favor [2] - The board approved the "2025 Mid-Year Profit Distribution Plan," with a unanimous vote of 7 in favor [2] - The board approved the "2025 Quality Improvement and Efficiency Enhancement Action Plan's Half-Year Evaluation Report," with a unanimous vote of 7 in favor [3] - The board approved the proposal to establish the "Information Disclosure Postponement and Exemption Management System," with a unanimous vote of 7 in favor [3] - The board approved the proposal for the sale of equity in an associated company, with a unanimous vote of 7 in favor, aimed at optimizing asset structure and increasing operational funds [3]